Navigation Links
Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
Date:12/19/2007

National Psoriasis Foundation urges psoriasis patients to take control of their health, help work for a cure

PORTLAND, Ore., Dec. 19 /PRNewswire-USNewswire/ -- A study released this week showing that people with severe psoriasis are likely to have a shorter life expectancy should prompt them to take steps to improve their overall health, according to the National Psoriasis Foundation.

The study -- published in the Archives of Dermatology and conducted by Joel M. Gelfand, M.D., M.S.C.E., and colleagues at the University of Pennsylvania School of Medicine -- showed that risk of death increased by 50 percent among patients with severe psoriasis.

Men with severe psoriasis died an average of 3.5 years sooner than male patients without the disease, the study showed. Women died an average of 4.4 years earlier than women without the condition. Mild psoriasis did not show an association with an increased risk of death. The study, which tracked patients in the United Kingdom from 1987 to 2002, defined people as having severe psoriasis if they were using systemic treatments. The study was done before the systemic treatments known as biologics were available for psoriasis or a related condition, psoriatic arthritis. Today, biologics are widely used to treat moderate to severe psoriasis.

The researchers do not know why patients with severe psoriasis have an increased risk of death, said Dr. Gelfand, a member of the National Psoriasis Foundation Medical Board. More research is needed to determine if severe psoriasis is a direct cause of a shorter life span or if factors associated with severe psoriasis such as smoking, drinking, obesity or social isolation are the cause. Researchers also are looking to see if certain treatments affect life expectancy.

"In the meantime, patients suffering with severe psoriasis are encouraged to lead a healthy lifestyle and to see their physicians for preventative health screenings and treatments
'/>"/>

SOURCE National Psoriasis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 MEI Pharma, Inc. ... on the clinical development of novel therapies for ... effects of the Company,s investigational drug candidate ME-344 ... when combined with a tyrosine-kinase inhibitor (TKI). In ... be a potent inhibitor of mitochondrial oxidative phosphorylation ...
(Date:5/4/2015)... 4, 2015  Geneia, a company of experienced ... to improve healthcare efficiencies, today announced a first-of-its-kind ... (BNRC) use Geneia,s advanced analytics solution coupled ... quality and lower the cost of patient care. ... claims and utilization data from multiple sources to ...
(Date:5/4/2015)... 2015 Intarcia Therapeutics, Inc. ... into the newly created role of Chief ... pharmaceutical executive with world-class experience – most recently ... service at industry leaders such as Pfizer and ... range of therapeutic areas, including: cardiovascular, metabolic, oncology, ...
Breaking Medicine Technology:MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4
(Date:5/4/2015)... In a continuing effort to remain ... Per Wickstrom, the founder of Choices Recovery in South ... “Salute to the Oscars” celebration held on February ... floor of the luxurious Beverly Hilton Hotel. , ... sustainable product placement in TV and film, this daylong ...
(Date:5/4/2015)... May 04, 2015 McNeil & ... announces the expansion of coverage for its Emergency ... provider of industry-tailored insurance and proactive risk management to ... we are dedicated to providing our customers with unparalleled ... many evolving needs. We are excited to launch over ...
(Date:5/4/2015)... Orange, NJ (PRWEB) May 04, 2015 ... non-profit organization devoted exclusively to funding innovative lymphoma research ... of education programs, outreach initiatives and patient services – ... at the historic Mayfair Farms in West Orange, NJ ... raised nearly $500,000 for innovative research programs through LRF. ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 METTLER ... The Importance of Data Integrity in a GXP ... as guest presenter. This webinar will be presented ... GMT). , Data integrity is a critical component ... to regulatory agencies. However, in recent years an ...
(Date:5/4/2015)... Seattle, WA (PRWEB) May 04, 2015 ... of a collaboration to facilitate development of NM108, a ... disorders that lead to blindness, including Diabetic Retinopathy. ... formulation platform developed by EyeCRO, which can deliver drugs ... a topical eyedrop. , Under the terms of ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3
... it is commonly thought that men with low IQs ... sexual deviance, new research has found the men may ... education previously taken. , A team of North ... without an intellectual disability and a history of sexual ...
... Following a spate of accidental infant,suffocation deaths in Detroit ... awarded a $25,000 grant to support a community-based,initiative called ... safe place for newborns to sleep. The grant is ... is to improve the health status,of all Michigan residents, ...
... and reduce risk of ... medication errors, ... to continually improve patient safety,and staff efficiency, Omnicell, Inc. (Nasdaq: ... and Grant Regional Health,Center, a leading healthcare provider, today announced the ...
... N.C., Oct. 16 As the pace ... their market research,groups to keep up. Effective ... by using customers, markets and competitors as,reference ... according to,research from benchmarking leader Best Practices, ...
... Herley Industries,Inc. (Nasdaq: HRLY ) announced today ... been awarded a contract valued at,approximately $5 million ... produce high power amplifiers for EDO,s CVRJ (CREW,Vehicle ... CEO, commented, "EDO has recently,announced awards with options ...
... vomiting, researchers say , TUESDAY, Oct. 16 (HealthDay News) ... sushi and sashimi -- increases the risk of infection ... severe stomach and intestinal problems such as diarrhea, cramping, ... emergency department, say two cases studies by Japanese researchers. ...
Cached Medicine News:Health News:'Corrective' sex education may make sexual offenders more dangerous 2Health News:Blue Cross Blue Shield of Michigan Awards Grant to Reduce Accidental Infant Suffocations in Wayne County 2Health News:Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems 2Health News:Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems 3Health News:Creating an Effective Market Research Group to Generate High-Impact Business Results 2Health News:Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs 2Health News:Raw Seafood Poses Digestive Risks 2
... Eppendorf Multipurpose Centrifuges feature ... accommodate a variety of rotors ... are three centrifuges in one: ... centrifuge for cell harvesting; a ...
Inquire...
Inquire...
Inquire...
Medicine Products: